NOVEL DRUG FORMULATION

摘要

There is provided inter alia a pharmaceutical aqueous nanosuspension comprising (i) 4-(4-ethyl-5-fluoro-2-hydroxyphenoxy)-3-fluorobenzamide in nanoparticulate form and a stabilizing agent.